Cytek Biosciences Inc [CTKB]
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 17.97% | 15.96% | 10.05% |
| Loss % | -18.03% | -12.93% | 12.23% |
| Duration | 13.3d | 14d | 5.0d |
| Total Pivots Found | 7 |
| Gain/Loss Legs | 6 (3 Gain / 3 Loss) |
| Last Pivot | Bottom @ $3.77 on 2026-06-18 |
| Change since Last Pivot | $0.00 (0.00%) |
Next Pivot Prediction Last: $0.00
| Predicted Next Type | Top |
| Predicted Price (Avg) | $4.45 |
| Predicted Price (Median) | $4.37 |
| Predicted Price Range (~68%) | $4.07 - $4.83 |
| Change to Avg Target | $4.45 (N/A) |
| Predicted Date (Avg) | 2026-07-01 |
| Predicted Date Range (~68%) | 2026-06-26 - 2026-07-06 |
| Basis | Based on 3 historical gains (Avg: 17.97%, Median: 15.96%, StdDev: 10.05%) and duration (Avg: 13.3 days, StdDev: 5.0 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Cytek Biosciences Inc plummets -5.28%.
Cytek Biosciences Inc (CTKB) stock price slumped on Thursday after the stock fell $-0.210 (-5.28%) from the previous session on extraordinarily high volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 1.91% rise. With 18.26M shares traded, volume yesterday reached $68.84M. This was 16.23M shares more than the prior day. Compared to the 10-day average of 1.59M shares, volume was more than the average.
Cytek Biosciences Inc signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Strong Bearish Consensus: A significant wave of negative pressure is evident across all time horizons. Technical indicators are decisively bearish in the short-term (20/30, net -56.7%), medium-term (20/30, net -56.7%), and long-term (20/30, net -56.7%), signaling a robust and sustained downtrend.
Cytek Biosciences Inc Support & Resistance Levels
The stock is trading above the closest support level at $3.55. approximately $0.220 (5.84%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s13.55 -
Cytek Biosciences Inc Evaluation
- Short score: -4.69
- Medium score: -6.47
- Long score: -6.25